Stocktoria
Advanced Biomed Inc. ADVB
Nasdaq · XNAS · stock · Services-Medical Laboratories · website · IPO 2025-03-06
Advanced Biomed Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 |
|---|---|---|
| R&D expense | $909,771 | $880,193 |
| Net income | -$3.3M | -$2.8M |
| EPS (diluted) | $-0.16 | $-0.14 |
| Operating cash flow | -$5.8M | -$2.1M |
| Free cash flow | -$5.9M | -$2.2M |
| Total assets | $13.7M | $4.5M |
| Total liabilities | $10.2M | $2.8M |
| Shareholders' equity | $3.5M | $1.7M |
Source: SEC EDGAR filings · CIK 0001941029 · as of 2025-06-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.